Falcon Point Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Falcon Point Capital’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,597,378	Closed	-$3.67M	–	120
2016 Q3	$3.67M	Sell	1,597,378 -603,311	-27%	-$1.53M	0.56%	42
2016 Q2	$5.19M	Sell	2,200,689 -263,855	-11%	-$728K	0.9%	45
2016 Q1	$7.96M	Buy	2,464,544 +615,967	+33%	+$2.28M	1.37%	40
2015 Q4	$8.86M	Buy	1,848,577 +1,363,519	+281%	+$7.73M	1.91%	24
2015 Q3	$2.7M	Buy	485,058 +5,541	+1%	+$40.9K	0.96%	40
2015 Q2	$3.82M	Buy	479,517 +345,563	+258%	+$2.97M	1.29%	36
2015 Q1	$1.41M	Buy	133,954 +27,573	+26%	+$377K	1.09%	36
2014 Q4	$1.28M	Sell	106,381 -18,909	-15%	-$287K	1.17%	31
2014 Q3	$2.14M	Buy	125,290 +101,474	+426%	+$1.47M	1.81%	12
2014 Q2	$287K	Sell	23,816 -14,276	-37%	-$135K	0.29%	98
2014 Q1	$321K	Buy	+38,092	New	+$307K	0.31%	97

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return

Falcon Point Capital's BDSI Position: Q4 2016 in Review

Falcon Point Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2016, closing a stake of 1,597,378 shares — an estimated $3.67M sold.

Falcon Point Capital first reported a position in BDSI in Q1 2014 and held it in 11 quarters. The position peaked at $8.86M in Q4 2015. 77 funds tracked by Wall St. Rank hold BDSI as of Q4 2016.

Falcon Point Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2016 after selling out during the quarter.
Falcon Point Capital sold 1,597,378 BioDelivery Sciences International, Inc. shares in Q4 2016, an estimated $3.67M.
Falcon Point Capital first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 11 quarters.
Falcon Point Capital's BioDelivery Sciences International, Inc. position peaked at $8.86M in Q4 2015.
77 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2016.

Based on Falcon Point Capital's 13F filing for Q4 2016, filed 7 Feb 2017.